Entrepreneurs - ONG - StartUp

DHHS-CGH: Scaling Up High-Impact HIV Prevention, Testing and Treatment Models in Central America Under PEPFAR

DHHS-CGH: Scaling Up High-Impact HIV Prevention, Testing and Treatment Models in Central America Under PEPFAR

Deadline: 19 February 2020

The Department of Health and Human Services, Centres for Disease Control is seeking applications for its Scaling Up High-Impact HIV Prevention, Testing and Treatment Models in Central America under the President’s Emergency Plan for AIDS Relief (PEPFAR).

Goals

  • Achieving primary prevention of HIV infection through activities such as expanding confidential counseling and testing programs linked with evidence based behavioral change and building programs to reduce mother-to-child transmission;
  • Improving the care and treatment of HIV/AIDS, sexually transmitted infections (STIs), and related opportunistic infections by improving STI management; enhancing laboratory diagnostic capacity and the care and treatment of opportunistic infections; interventions for intercurrent diseases impacting HIV infected patients including tuberculosis (TB); and initiating programs to provide anti-retroviral therapy (ART);
  • Strengthening the capacity of countries to collect and use surveillance data and manage national HIV/AIDS programs by expanding HIV/STI/TB surveillance programs and strengthening laboratory support for surveillance, diagnosis, treatment, disease monitoring, and HIV screening for blood safety;
  • Developing, validating, and/or evaluating public health programs to inform, improve, and target appropriate interventions, as related to the prevention, care and treatment of HIV/AIDS, TB, and opportunistic infections.

Program Outcomes

Short-Term Outcomes

  • Increased access to HIV testing among key populations and partners of index cases
  • Increased access to PreP among individuals at highest risk of HIV infection
  • Increased availability and analysis of HIV rapid recency results
  • Improved effective linkage to care and treatment among individuals newly diagnosed with HIV
  • Increased early treatment initiation, retention and adherence among PLHIV
  • Improved access to viral load testing among PLHIV
  • Improved monitoring of HIV drug resistance
  • Increased adoption of PEPFAR-supported strategies within national guidelines and manuals

Intermediate Outcomes

  • Increased HIV case finding among key populations and partners of index cases
  • Reduced late HIV diagnosis among key populations and partners of index cases
  • Sustained negative HIV test results among individuals on PreP
  • Improved public health response to clusters of active HIV transmission
  • Improved treatment initiation rates among key populations and partners of index cases
  • Improved viral load suppression among PLHIV
  • Increased coverage of PEPFAR-supported strategies at the national level

Long-Term Outcomes

  • Increased country ownership of PEPFAR-supported initiatives

Funding Information

  • Approximate Total Fiscal Year Funding: $5,000,000

Eligibility Criteria

  • Government Organizations:
    • Political subdivisions of States (in consultation with States)
  • Non-government Organizations:
    • Alaska Native health corporations
    • Tribal epidemiology centers
    • Urban Indian health organizations
    • Nonprofit with 501C3 IRS status (other than institution of higher education)
    • Nonprofit without 501C3 IRS status (other than institution of higher education)
    • Research institutions (that will perform activities deemed as non-research)
  • Colleges and Universities
  • Community-based organizations
  • Faith-based organizations (FBOs)
  • For-profit organizations (other than small business)
  • Hospitals
  • Small, minority, and women-owned businesses
  • All Other

For more information, visit https://www.grants.gov/web/grants/view-opportunity.html?oppId=319479

Laisser un Commentaire

En savoir plus sur Concoursn.com

Abonnez-vous pour poursuivre la lecture et avoir accès à l’ensemble des archives.

Continue reading